Επιλογή Σελίδας

Δημήτρης Χατζής

Επισκέπτης Επίκουρος Καθηγητής, Καρδιολογία

Ιατρική Σχολή

ΕΠΙΣΚΕΠΤΗΣ ΚΑΘΗΓΗΤΗΣ

Ακαδημαϊκα Προσοντα

Ακαδημαϊκός Τίτλος 

Έτος 

Ίδρυμα 

Τμήμα 

Τίτλος Διατριβής (Καταχωρείται προαιρετικά) 

PhD 

2010 

National and Kapodistrian University of Athens, Greece 

Medicine  

Diastolic dysfunction estimation in hypertensive patients with TDI: Correlations with great artery stiffness and BNP plasma levels 

Medical Degree  

1999 

National and Kapodistrian University of Athens, Greece 

Medicine  

 

Post Graduate Certificate  

2009 

Institute for Therapy Advancement (ITA), Paris, France  

Interventional Cardiology  

 

 

Ιστορικο Εργοδοτησης

Period of employment 

Employer 

Location 

Position 

From 

To 

9/2018  

4/2022 

European University Cyprus  

Nicosia, Cyprus  

Scientific Collaborator 

10/2002 

10/2009 

Hypertension Unit, 1st Cardiology Clinic, NKUA  

Athens, Greece  

Scientific Collaborator 

Δημοσιευσεις

Year 

Title 

Other authors 

Journal and Publisher /  
Conference 

Vol. 

Pages 

2022 

Role of diabetes in stroke: Recent advances in pathophysiology and clinical management 

Sian A Bradley, Kevin J Spring, Roy G Beran, Dimitrios Chatzis, Murray C Killingsworth, Sonu M M Bhaskar 

Diabetes Metab Res Rev 

. 

38(2) 

e3495 

2021 

Changing the Concept: From the Traditional Glucose-centric to the New Cardiorenal-metabolic Approach for the Treatment of Type 2 Diabetes 

Dimitrios G Chatzis, Konstantinos Kolokathis, Kalliopi Magounaki, Stefanos Chatzidakis , Konstantinos Avramidis, Marianna Leopoulou, Theodoros P Angelopoulos, John Doupis  

Touch REV Endocrinol 

7(2) 

92-101. 

2021 

Critical emergency medicine and the resuscitative care unit 

Mermiri M, Mavrovounis G, Chatzis D, Mpoutsikos I, Tsaroucha A, Dova M, Angelopoulou Z, Ragias D, Chalkias A, Pantazopoulos I 

Acute Crit Care 

36(1) 

22-28 

2020 

Peripherally Inserted Central Catheter lines for Intensive Care Unit and onco-hematologic patients: A systematic review and meta-analysis 

Mavrovounis G, Mermiri M, Chatzis DG, Pantazopoulos I 

Heart Lung 

49(6) 

922-933 

2020 

COVID-19 pandemic and cardiovascular disease: where do we stand? 

 

Chatzis DG, Magounaki KT, Pantazopoulos IN, Johnson EO, Tsioufis KP 

Minerva Cardioangiol. 

68(4) 

347-358 

 

Εκθεσεις

Date 

Topic 

International / Local 

Location* 

Role in Exhibition 

2022 

Management of hypertension in the old and very elderly patients 

6th School of Hypertension  

Athens, GR 

Instructor 

2021 

Management of patients with heart failure and renal failure 

Panhellenic congress of cardiometabolic risk factors, obesity and diabetes  

Lefkas, GR  

Invited speaker  

2021 

Management of hypertension in the elderly population 

5th School of Hypertension  

 

Athens, GR 

 

Instructor 

2020 

How to treat Atrial Fibrillation  

2020 MEETING OF THE WORKING GROUP ON OBESITY, DIABETES AND THE HIGH RISK PATIENT, EUROPEAN SOCIETY OF HYPERTENSION 

Chalkidiki, GR 

Moderator  

2018 

Anticoagulant therapy in high risk patients with atrial fibrillation  

2020 MEETING OF THE WORKING GROUP ON OBESITY, DIABETES AND THE HIGH RISK PATIENT, EUROPEAN SOCIETY OF HYPERTENSION 

Chalkidiki, GR 

Invited speaker 

Ερευνητικα Projects

Date 

Title 

Funded by 

Project Role* 

2016 

PAVE – AF (Pattern of Antithrombotic therapy in Very Elderly patients with Atrial Fibrillation) non – interventional multicenter Greek study. 

Pfizer Ltd  

Lead Clinician  

2014 

TIGREECE multicenter national trial regarding the long term outcomes of Greek patients one year after myocardial infarction 

Astra Zeneca Ltd 

Principal Investigator 

2022  

DEFINE - AF (DEtection of atrial FIbrillatioN in Elderly hypertensive pAtients with leFt atrial enlargement in Greece) 

Pfizer Ltd 

Principal Investigator and Private practice cardiologists’ coordinator 

2010 

VALENTINES TRIAL (multicenter international trial regarding the effectiveness of the drug – eluting balloon Dior in the treatment of in stent restenosis 

EuroCor 

Research Team member 

2008  

ROCKET AF (Rivaroxaban Once daily Oral Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation 

Bayer Ltd 

Research Team member 

 

Ακαδημαϊκες Συμβουλευτικες Υπηρεσιες/Συμμετοχη σε Συμβουλια/Επιτροπές

Period 

Organization 

Title of Position or Service 

11/2016 – 01/2019 

Pfizer Ltd  

Senior Medical Advisor  

 

Βραβευσεις/Διεθνεις Διακρισεις

Date 

Title 

Awarded by: 

2015 

Clinical Hypertension Specialist 

European Society of Hypertension  

2015  

Full registration with license to practice in the specialist doctors list  

General Medical Council (GMC), U.K. 

2022 

Referee, ESH congress 2022, Athens, GR 

European Society of Hypertension 

 

Αλλες Διακρισεις